By Josh White
Date: Tuesday 19 May 2026
(Sharecast News) - EKF Diagnostics said in an update on Tuesday that trading so far in 2026 remained in line with management expectations, supported by strong cash generation and continued momentum in its hematology and life sciences businesses.
By Josh White
Date: Monday 13 Apr 2026
(Sharecast News) - EKF Diagnostics announced on Monday that it has acquired technology assets from Sweden-based Beep Insights to enhance its sports performance offering, adding real-time glucose and lactate tracking capabilities to its product suite.
By Josh White
Date: Tuesday 03 Mar 2026
(Sharecast News) - EKF Diagnostics announced the signing of a three-year group purchasing agreement with Blood Centers of America on Tuesday, securing access to more than 60 independent community blood centres across the US.
| Currency | UK Pounds |
| Share Price | 27.20p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 31.90 |
| 52 Week Low | 21.80 |
| Volume | 68,838 |
| Shares Issued | 430.90m |
| Market Cap | £117.21m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 3 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 02-Nov-23 | 03-Nov-22 |
| Paid | 01-Dec-23 | 01-Dec-22 |
| Amount | 1.20p | 1.20p |
| Time | Volume / Share Price |
| 14:25 | 4 @ 27.40p |
| 14:08 | 5,180 @ 26.93p |
| 14:04 | 17,364 @ 26.98p |
| 13:22 | 15 @ 26.90p |
| 12:04 | 35,350 @ 27.10p |
| CEO | Gavin T Jones |
| CFO | Helen Jones FCA |
You are here: research